Loading clinical trials...
Loading clinical trials...
A Phase 1, Randomized, Single-blind, Placebo-controlled Study to Investigate the Pharmacokinetics, Safety, Tolerability, and Efficacy of AZD0780 in Combination With Ezetimibe, Ezetimibe/Rosuvastatin, or Ezetimibe/Bempedoic Acid in Healthy Male and Female Participants 18 to 75 Years of Age With Elevated LDL-C.
Conditions
Interventions
AZD0780
Ezetimibe
+3 more
Locations
3
United States
Research Site
Glendale, California, United States
Research Site
Brooklyn, Maryland, United States
Research Site
Harrow, United Kingdom
Start Date
December 20, 2024
Primary Completion Date
October 29, 2025
Completion Date
October 29, 2025
Last Updated
November 10, 2025
NCT07238556
NCT06314919
NCT07162441
NCT06935513
NCT06932705
NCT06568471
Lead Sponsor
AstraZeneca
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions